A recent article in the Washington Post states that federal investigators want to prevent drug companies with executives who have been involved in fraud from doing business with the US Government. The new guidelines were posted on October 20 on the office's webpage. This will help keep individuals accountable for their actions.
A few of the new sanctions include:
-Company executives might also be sanctioned if their employers are convicted of misconduct or they may be blocked from doing business with federal agencies.
-Misconduct
-Misdemeanor convictions
What do you think about these new sanctions? Will it allow the government to keep their employees more honest?
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
November
(7)
- Medicare cuts delayed once again
- Government Programs 2011: Brochure now available f...
- Preventing business if drug companies executives a...
- The Medicare Congress Podcast: John Gorman of Gorm...
- My Medicare Advocate helps seniors navigate Medica...
- Louisiana sues drug companies for fraud
- AMA on the current elections
-
▼
November
(7)
No comments:
Post a Comment